Log in

Relevant bibliographies by topics / Glasgow Antipsychotic Side-effect Scale (GASS) / Journal articles

To see the other types of publications on this topic, follow the link: Glasgow Antipsychotic Side-effect Scale (GASS).

Journal articles on the topic 'Glasgow Antipsychotic Side-effect Scale (GASS)'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 37 journal articles for your research on the topic 'Glasgow Antipsychotic Side-effect Scale (GASS).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sterritt, James. "Monitoring side-effects of antipsychotics using the glasgow antipsychotic side-effect scale." BJPsych Open 7, S1 (2021): S106—S107. http://dx.doi.org/10.1192/bjo.2021.315.

Full text

Abstract:

AimsAntipsychotic drugs frequently produce side-effects which represent common reasons for noncompliance. National guidelines, published by the National Institute of Care and Health Excellence, the Royal College of Psychiatrists, and the Maudsley Prescribing Guidelines in Psychiatry, stipulate that patients prescribed antipsychotic drugs should be reviewed for side-effects on a weekly basis. This completed audit cycle, conducted on a mixed acute general adult psychiatric ward, examined whether patients were being assessed for side-effects of antipsychotic drugs using a standardised, self-repor

APA, Harvard, Vancouver, ISO, and other styles

2

Hasni, Dita, Vivinia Rahmi Andika Putri, and Mutiara Anissa. "Identification of Antipsychotic Side Effects with Glassgow Antipsychotic Side-Effect Scale (GASS)." Journal of Health Science and Prevention 4, no. 2 (2020): 85–90. http://dx.doi.org/10.29080/jhsp.v4i2.268.

Full text

Abstract:

Schizophrenia is ranked 4th of the top 10 diseases that burden worldwide. If the population of Indonesia reaches 200 million, it estimates that around two million have Schizophrenia. Based on Data from the World Health Organization (WHO), it estimates that around 24 million people worldwide have schizophrenia.2 the American Psychiatric Association (APA) were reported the incidence of Schizophrenia in the United States is about 1% of the adult population with a total of more than 2 million people. Schizophrenic patients were treated by antipsychotic agents that act to inhibit dopamine receptors

APA, Harvard, Vancouver, ISO, and other styles

3

Rodolico, Alessandro, Carmen Concerto, Alessia Ciancio, et al. "Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders." Brain Sciences 12, no. 7 (2022): 891. http://dx.doi.org/10.3390/brainsci12070891.

Full text

Abstract:

Antipsychotics are a class of psychotropic drugs that improve psychotic symptoms and reduce relapse risk. However, they may cause side effects (SE) that impact patients’ quality of life and psychosocial functioning. Therefore, there is a need for practical tools to identify them and possibly intervene. The objective of the present study was to translate into Italian the Glasgow Antipsychotic Side Effect Scale (GASS), which is suggested as the questionnaire of choice to collect SE reported by patients treated with antipsychotics. We administered the GASS and the Udvalg for Kliniske Undersøgelse

APA, Harvard, Vancouver, ISO, and other styles

4

Singh, Hardeep, Maryam Syed, Vimal Mannali, and Ekta Sharma. "Assessing Adherence: Audit of Glasgow Antipsychotic Side-Effect Scale Completion for Patients on Antipsychotic Depot Injections at Guildford CMHRS SABP." BJPsych Open 10, S1 (2024): S169—S170. http://dx.doi.org/10.1192/bjo.2024.435.

Full text

Abstract:

AimsTo evaluate the current use of the GASS scale in monitoring patients on antipsychotic depot medications at Guildford CMHRS, we conducted a comprehensive assessment and compared it with trust guidelines. The guidelines recommend GASS scale completion at specific intervals: 12 weeks and 6 months post-initiation, annually thereafter, and at each dose titration.MethodsWe conducted a review of patient depot charts and SystmOne notes for individuals on antipsychotic depot medications, in accordance with trust guidelines. Cases were randomly selected from the total number of patients on these med

APA, Harvard, Vancouver, ISO, and other styles

5

Bock, Marlene S., Oona N. van Achter, David Dines, et al. "F28. CLINICAL VALIDATION OF THE GLASGOW ANTIPSYCHOTIC SIDE EFFECT SCALE (GASS)." Schizophrenia Bulletin 45, Supplement_2 (2019): S265. http://dx.doi.org/10.1093/schbul/sbz018.440.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sodiya, Olusegun, Adewole Adegoke, Geanina Ilinoiu, and Clare Morgans. "Clinical Audit on the Measurement of Antipsychotic Side Effects Using Rating Scales (GASS, LUNSERS, and SESCAM) in Community Settings." BJPsych Open 9, S1 (2023): S182—S183. http://dx.doi.org/10.1192/bjo.2023.475.

Full text

Abstract:

AimsThis clinical audit aimed to assess if monitoring of side effect of antipsychotics is adhered to using the Trust and National institute of clinical excellence (NICE) guidelines.One of the determinants of prognosis in schizophrenia is compliance to medications. Hence, the importance to monitor patient's tolerability of side effects when they are on antipsychotic medications. Several patients during episodes of relapse have reported that experience of side effects were their main reasons for defaulting on their medications. This underpins the importance to monitor patients’ tolerability of s

APA, Harvard, Vancouver, ISO, and other styles

7

Haw, Camilla, Ayesha Muthu-Veloe, Mark Suett, Oghodafetite Ibodor, and Marco Picchioni. "Monitoring antipsychotic side effects: a competed audit cycle conducted in a secure hospital." Journal of Forensic Practice 18, no. 3 (2016): 182–88. http://dx.doi.org/10.1108/jfp-06-2015-0034.

Full text

Abstract:

Purpose – The purpose of this paper is to describe a completed audit cycle of the assessment and documentation of antipsychotic side effects reported by patients in a secure hospital setting. Design/methodology/approach – The initial audit was carried out in 2012. As a result of the findings clinicians were recommended to use a brief structured side effect monitoring guide (the Glasgow Antipsychotic Side-Effect Scale (GASS-m)). The audit was repeated in 2015. Findings – Of the 41 patients notes included in the initial audit, for only one (2.4 per cent) was there evidence of a systematic and st

APA, Harvard, Vancouver, ISO, and other styles

8

Paton, Cristina, Siggi Hammond, James Hills, Leah Jones, and Eugene Wong. "GASS-tly side effects: antipsychotic monitoring for inpatients across NHS Lanarkshire." BJPsych Open 7, S1 (2021): S97. http://dx.doi.org/10.1192/bjo.2021.293.

Full text

Abstract:

AimsBest practice in the prescribing of antipsychotic therapy includes monitoring for medication side effects. National guideline SIGN 131 advises the use of a validated side effect scale, for example the Glasgow Antipsychotic Side-effect Scale (GASS). Local recommendation in NHS Lanarkshire advises that patients prescribed antipsychotic therapy should be offered GASS at each contact and after initiation or titration. We aimed to improve compliance with antipsychotic side effect monitoring for inpatients in general adult psychiatry across two hospital sites in NHS Lanarkshire.MethodWe conducte

APA, Harvard, Vancouver, ISO, and other styles

9

Waterman, Harry, Hanna Zaborowska, and Julie Taylor. "Side-Effect Monitoring for Patients on Depot Antipsychotic Medication Within a Community Treatment Team." BJPsych Open 9, S1 (2023): S186—S187. http://dx.doi.org/10.1192/bjo.2023.483.

Full text

Abstract:

AimsTo determine whether the community treatment team (CTT) were meeting the following three trust standards for patients receiving antipsychotic depot medication: 1. 100% of patients should have side effects monitored using a validated scoring system in the form of the Glasgow Antipsychotic Side-effect Scale (GASS) once yearly. 2. 100% of patients should have had a GASS completed ever. 3. 100% of patients with a completed GASS should have this document available in full. Additionally adherence to these measures was compared to the previous year's audit to assess for change following intervent

APA, Harvard, Vancouver, ISO, and other styles

10

Tait, Andrew, and Eugene Wong. "Completion Audit of Inpatient Glasgow Anti-Psychotic Side-Effect Scale (GASS) Forms." BJPsych Open 10, S1 (2024): S264—S265. http://dx.doi.org/10.1192/bjo.2024.636.

Full text

Abstract:

AimsSide-effects are a recognised burden of all medications and are linked to poor compliance. In psychiatry, poor compliance can result in a relapse and significant deterioration in mental health. This has an impact on both the patient and the wider healthcare system. It has been speculated that if patients had more control/recognition of side-effects, compliance would increase.GASS is a self-rating scale for side-effects of antipsychotic medication. It has the added effect of being able to stratify side-effects by their severity and biological system involved (Central Nervous System (Sedatin

APA, Harvard, Vancouver, ISO, and other styles

11

Mohamed, Ahmed Adel, Abdulaziz Saleh Almulhim, Abdulrahman Abdullah Alnijadi, et al. "Evaluation of Prescription Patterns of Antipsychotics in Schizophrenia Patients—A Single-Center Prospective Study." Journal of Clinical Medicine 14, no. 9 (2025): 2941. https://doi.org/10.3390/jcm14092941.

Full text

Abstract:

Inappropriate prescription patterns and polypharmacy are critical challenges facing the optimal management of schizophrenia patients, especially in regard to patient safety. Background/Objectives: The purpose of this study was to examine the relationship between patient safety and the existence of incorrect prescription patterns and/or polypharmacy in the medications prescribed to individuals with schizophrenia. This issue is addressed in a broad context, highlighting the purpose of this study. Methods: A cross-sectional study was adopted, involving a prospective analysis of the prescriptions

APA, Harvard, Vancouver, ISO, and other styles

12

Ristic, D. Ignjatovic, C. Dan, D. Hinic, and J. Jovic. "Subjective well-being under clozapine measured with the Serbian version of GASS-C: Preliminary results." European Psychiatry 41, S1 (2017): s815. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1584.

Full text

Abstract:

IntroductionClinical benefits of antipsychotic treatment depend on the efficacy and on the patients’ tolerability and compliance. To reduce patient initiated treatment discontinuation, timely detection of treatment emergent side effects is essential. The Glasgow Antipsychotic Side-effects scale for clozapine (GASS-C) is a recently developed instrument to measure subjectively experienced clozapine side effects.ObjectivesTimely detection of unreported clozapine related side-effects.AimDocumenting the prevalence of side-effects in schizophrenia or chronic psychotic disorder with the Serbian versi

APA, Harvard, Vancouver, ISO, and other styles

13

Alam Fatmi, yed Meraj. "Severity in schizophrenia patients receiving atypical antipsychotic medications." Bioinformation 18, no. 12 (2022): 1154–58. http://dx.doi.org/10.6026/973206300181154.

Full text

Abstract:

Atypical antipsychotic drugs are nowadays the mainstay of treatment of schizophrenia due to their lesser extrapyramidal symptoms (EPS) as adverse effects. However, these drugs have different profiles of adverse drug reactions (ADRs). Here, the objective of this study was to analyze the probability, occurrences, and more significant involvement of various risk factors. A prospective observational study was carried out on a patient with schizophrenia who has prescribed atypical antipsychotic drugs for their treatment. The probability of the ADR was analyzed by using the Naranjo causality assessm

APA, Harvard, Vancouver, ISO, and other styles

14

AlRuthia, Yazed, Hadeel Alkofide, Fahad Dakheel Alosaimi, et al. "Translation and cultural adaptation of Glasgow Antipsychotic Side-effects Scale (GASS) in Arabic." PLOS ONE 13, no. 8 (2018): e0201225. http://dx.doi.org/10.1371/journal.pone.0201225.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Concerto, Carmen, Alessandro Rodolico, Ludovico Mineo, et al. "Exploring Personal Recovery in Schizophrenia: The Role of Mentalization." Journal of Clinical Medicine 12, no. 12 (2023): 4090. http://dx.doi.org/10.3390/jcm12124090.

Full text

Abstract:

Recovery is a broadly debated concept in the field of psychiatry research and in schizophrenia. Our study aims to understand the correlation between personal recovery from schizophrenia and factors such as mentalization, disability, quality of life, and antipsychotic side effects; Methods: Participants with schizophrenia (according to DSM-5 criteria) were consecutively recruited from the Psychiatry Unit of the University of Catania, Italy. Participants were assessed with the Recovery Assessment Scale (RAS), the Multidimensional Mentalizing Questionnaire (MMQ), the brief version of the WHO Disa

APA, Harvard, Vancouver, ISO, and other styles

16

Sahadevan, Sreeja, Melissa Hicks, Reena Tharian, Elizabeth Patteril, and Regi Alexander. "Anticholinergic Burden in People With Learning Disability and Mental Health Difficulties: A Baseline Audit." BJPsych Open 10, S1 (2024): S259. http://dx.doi.org/10.1192/bjo.2024.625.

Full text

Abstract:

AimsBackground:The cumulative effect of having one or more prescription drugs with anticholinergic properties is known as the Anticholinergic Burden (ACB). ACB can increase mortality and morbidity. Adults with learning disability are a high-risk group for this.Aims:To evaluate Anticholinergic Burden (ACB) for adults with learning disability and co-existing mental health conditions and make practice recommendations.MethodsA baseline audit was carried out over a period of 1 month on those treated within two specialist in-patient units in England. Routinely collected information including diagnos

APA, Harvard, Vancouver, ISO, and other styles

17

Mitchell, Shalina, and Prabin Gautam. "Procyclidine Use in Long-Acting Injectable Antipsychotics." BJPsych Open 11, S1 (2025): S237. https://doi.org/10.1192/bjo.2025.10592.

Full text

Abstract:

Aims: Following a Serious Untoward Incident investigation into a patient death where blood tests revealed procyclidine overdose, significant concerns emerged regarding procyclidine prescribing practices. A notable discrepancy was identified between the Summary of Product Characteristics and British National Formulary regarding maximum daily procyclidine dosing, with evidence of 40 mg daily doses being administered. This raised questions about prescribing practices, particularly in patients receiving long-acting injectable antipsychotics. The incident highlighted the need to evaluate current pr

APA, Harvard, Vancouver, ISO, and other styles

18

Kitagawa, Kohei, Ryuhei So, Nobuyuki Nomura, et al. "Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)." PLOS ONE 15, no. 6 (2020): e0234864. http://dx.doi.org/10.1371/journal.pone.0234864.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Cheppalli, Vani* A. Nikhilesh K. Phani Sravya N. Jhansi Rani Md Abdul Mannan. "Prescription Patterns in Anti-Psychotic Medication and Drug Related Problems in Schizophrenia Patients." Journal of Pharma Research 9, no. 5 (2020): 8. https://doi.org/10.5281/zenodo.3881520.

Full text

Abstract:

ABSTRACT Objectives: The main objective of the study was prescription patterns of antipsychotics and drug related problems in schizophrenia patients. Methodology: A prospective observational study was conducted in psychiatry (OPD) of tertiary care hospital. The data was collected from OPD for a period of 6 months in 100 cases by using data collection forms Socio-demographic’s, Positive and Negative symptom assessment scale and Glasgow antipsychotic side effect scale used for detection of drug related problems. Statistics was done to the data by using SPSS software. Result: A total of 100

APA, Harvard, Vancouver, ISO, and other styles

20

Jupe, T., F. Elezi, B. Zenelaj, and E. Myslimi. "The side effects of risperidone depot in patients with psychotic disorders." European Psychiatry 41, S1 (2017): s816. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1586.

Full text

Abstract:

Background and aimA long-acting form of risperidone is now broadly available for the treatment of schizophrenia and closely related psychiatric conditions. It combines the advantage of previously available depot formulations for first-generation drugs with the favorable characteristics of the modern “atypical” antipsychotics, namely higher efficacy in the treatment of the negative symptoms of schizophrenia and reduced motor disturbances [1].MethodsDuring this study, we observed side effects that appear in patients that are treated with risperidone depot. Patients were observed for a period of

APA, Harvard, Vancouver, ISO, and other styles

21

Gee, Siobhan H., David M. Taylor, Sukhwinder S. Shergill, Robert Flanagan, and James H. MacCabe. "Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit." Therapeutic Advances in Psychopharmacology 7, no. 2 (2016): 79–83. http://dx.doi.org/10.1177/2045125316677027.

Full text

Abstract:

Background: Tobacco smoke is known to affect plasma levels of some drugs, including the antipsychotic clozapine. The effects of suddenly stopping smoking on patients who take clozapine can be severe, as plasma concentrations are expected to rapidly rise, potentially leading to toxicity. A ban on smoking at South London and the Maudsley NHS Foundation Trust (SLaM) was implemented in 2014, and this was expected to affect the plasma concentrations of clozapine for inpatients at the time. This study aimed to determine whether plasma concentrations of clozapine were affected, and additionally, in l

APA, Harvard, Vancouver, ISO, and other styles

22

Mitchell, Nathan, Aamer Sajjad, Anna Grocholewska-Mhamdi, and Catherine McMain. "Improving baseline and follow-up physical health monitoring when commencing oral antipsychotics." BJPsych Open 7, S1 (2021): S92. http://dx.doi.org/10.1192/bjo.2021.279.

Full text

Abstract:

AimsNICE guidelines suggest baseline physical health monitoring be performed prior to commencing antipsychotics, in addition to follow-up monitoring for adverse effects for at least 12 months. ‘Shared Care Guidelines’ were adapted from NICE guidance for local use in North East Lincolnshire. Nevertheless, a local audit published in 2018 reported low compliance with baseline monitoring in community mental health teams (CMHTs) compared to inpatient teams. The parameter most infrequently performed overall was the Glasgow Antipsychotic Side Effect Scale (GASS) questionnaire.This study aimed to asse

APA, Harvard, Vancouver, ISO, and other styles

23

NAUROSE ALI, ISMAIL TARIQ, UMEMA HABIB, and ALTAF QADIR KHAN. "THE ANXIOLYSIS CONUNDRUM: BENZODIAZEPINE VS LOW DOSE ANTIPSYCHOTIC." Pakistan Postgraduate Medical Journal 27, no. 4 (2016): 99–102. http://dx.doi.org/10.51642/ppmj.v27i4.108.

Full text

Abstract:

Background: The unprecedented and unaccounted use of benzodiazepines is running havoc in many countries in terms of substance abuse problems and is exponentially increasing. The prescription of benzodiazepines should be minimized and the search for and use of better alternatives be incorporated into clinical practice of Psychiatry. Aim: The aim of this study is to compare the efficacy of low dose Risperidone and relatively higher dosage of Clonazepam in moderate to severe anxiety states when used in combination with an SSRI. Method: A group of 60 patients having moderate to severe

APA, Harvard, Vancouver, ISO, and other styles

24

Febriana, Betie, Wigyo Susanto, Dwi Heppy Rochmawati, and Wahyu Endang Setiawati. "Family Support is the Key to Compliance with the Treatment of Relapsing Schizophrenia Patients." Jurnal Ners 15, no. 1Sp (2020): 457–61. http://dx.doi.org/10.20473/jn.v15i1sp.20361.

Full text

Abstract:

Introduction: One problem in treating schizophrenia patients is relapse. The previous study results state that the biggest factor causing relapse is non-compliance with taking medication. This non-compliance with taking medication is influenced by several factors, including patient sociodemography, drug side effects, and family support. The purpose of this study was to determine the factors associated with medication adherence in Schizophrenia patients who were undergoing rehospitalization in an inpatient installation at RSJD in one city in Central Java, Indonesia.Methods: This study is a desc

APA, Harvard, Vancouver, ISO, and other styles

25

Nomura, Nobuyuki, Kohei Kitagawa, Ryuhei So, et al. "Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study." Therapeutic Advances in Psychopharmacology 11 (January 2021): 204512532110161. http://dx.doi.org/10.1177/20451253211016189.

Full text

Abstract:

Background: There have been scarce data on the distribution of clozapine concentrations in comparison with the recommended range (350–600 ng/ml) or their relationship with side effects among patients with treatment-resistant schizophrenia. Furthermore, no studies have assessed the association between side effects and overall exposure to the drug by calculating the 24-h area-under-curve (AUC). Methods: In- and outpatients with schizophrenia or schizoaffective disorder (ICD-10) who were receiving a stable dose of clozapine for ⩾2 weeks were included. Side effects were assessed using the Glasgow

APA, Harvard, Vancouver, ISO, and other styles

26

Gautam, Prabin, Titilola Osoba, and Shalina Mitchell. "Procyclidine Use with Long-Acting Injectable Antipsychotics." BJPsych Open 11, S1 (2025): S132. https://doi.org/10.1192/bjo.2025.10367.

Full text

Abstract:

Aims: Our aim was to review if procyclidine is being prescribed as per BNF guidelines at DGS CMHT. As per BNF guidelines, procyclidine is recommended to be initiated at 2.5 mg of procyclidine three times per day increasing by 2.5 mg daily until symptoms are relieved. The effective maintenance dose is usually 10–30 mg procyclidine per day. After a period of 3–4 months of therapy, procyclidine should be withdrawn and the patient should be observed to see whether the neuroleptic-induced extrapyramidal symptoms recur.Methods: A retrospective clinical audit was conducted on 36 patients receiving lo

APA, Harvard, Vancouver, ISO, and other styles

27

Weiss, Catherine, Stine Rasmussen Meehan, William R. Lenderking, et al. "T220. IMPACT OF SECOND-GENERATION ANTIPSYCHOTIC SIDE EFFECTS ON FUNCTIONING FROM A SCHIZOPHRENIA PATIENT PERSPECTIVE: GLOBAL PATIENT CENTERED SURVEY INCLUDING PATIENTS FROM ITALY." Schizophrenia Bulletin 46, Supplement_1 (2020): S316—S317. http://dx.doi.org/10.1093/schbul/sbaa029.780.

Full text

Abstract:

Abstract Background Second-generation antipsychotics (SGAs) used to treat patients with schizophrenia generally have lower risk of motor side effects (SEs) than first-generation antipsychotics, but they are associated with other well-known SEs. The goal of this study was to understand how specific SEs of SGAs impact daily functioning, emotional well-being, and overall quality of life of patients with schizophrenia from their own perspective. Methods This study was a cross-sectional, participant-reported web survey, conducted globally during 2017–2018. The survey captured participants’ socio-de

APA, Harvard, Vancouver, ISO, and other styles

28

Schouby Bock, Marlene, Oona Nørgaard Van Achter, David Dines, et al. "Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference." Journal of Psychopharmacology 34, no. 8 (2020): 820–28. http://dx.doi.org/10.1177/0269881120916122.

Full text

Abstract:

Background: Antipsychotics are key for the treatment of psychotic and several non-psychotic disorders. Unfortunately, antipsychotic medications are associated with side effects, which may reduce quality of life and treatment adherence. Therefore, regular screening of antipsychotic side effects is essential. The Glasgow Antipsychotic Side-effect Scale is a patient self-report scale developed for this purpose. However, the Glasgow Antipsychotic Side-effect Scale has only been validated against another self-report side effect measure, which is suboptimal. Objective: We aimed to validate the Glasg

APA, Harvard, Vancouver, ISO, and other styles

29

Kassew, Tilahun, Demeke Demilew, Addis Birhanu, Mesele Wonde, Biks Liyew, and Shegaye Shumet. "Attitude towards Antipsychotic Medications in Patients Diagnosed with Schizophrenia: A Cross-Sectional Study at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia." Schizophrenia Research and Treatment 2019 (May 22, 2019): 1–9. http://dx.doi.org/10.1155/2019/5094017.

Full text

Abstract:

Background. Poor attitude towards antipsychotic drugs is high, and it is a factor for non-adherence to treatment. This increases the risk of relapse, associated healthcare utilization, and costs. This study aimed to assess attitude towards antipsychotic medication among patients with schizophrenia. Objectives. The aim of this institution based cross-sectional study was to assess attitude towards antipsychotic medications and associated factors among patients with schizophrenia who attend the outpatient clinics at Amanuel Mental Specialized Hospital, 2018. Methods. In a cross-sectional study, 3

APA, Harvard, Vancouver, ISO, and other styles

30

Gill, M., and M. McCauley. "Establishing a physical health monitoring service for patients on depot antipsychotic medication." European Psychiatry 33, S1 (2016): S564. http://dx.doi.org/10.1016/j.eurpsy.2016.01.2089.

Full text

Abstract:

IntroductionPatients with major mental illness are recognised to be at risk of premature death for a multitude of reasons. Those with schizophrenia and bipolar disorder are at highest risk.ObjectivesInternational best practice recommends monitoring of blood tests, physical parameters such as weight, BMI, waist circumference and blood pressure, and side effects of patients prescribed antipsychotic medication. A clinic was established to target these interventions.AimsThis initiative aimed to improve the physical health monitoring of patients prescribed depot antipsychotic medication in a catchm

APA, Harvard, Vancouver, ISO, and other styles

31

Calkins, Monica, Megan Westfall, and Irene Hurford. "M244. PENNSYLVANIA FIRST-EPISODE PROGRAM EVALUATION OF COORDINATED SPECIALTY CARE: SIX- AND 12-MONTH OUTCOMES." Schizophrenia Bulletin 46, Supplement_1 (2020): S228—S229. http://dx.doi.org/10.1093/schbul/sbaa030.556.

Full text

Abstract:

Abstract Background Interest in early intervention for first-episode psychosis (FEP) has increased globally in recent decades in response to evidence that multi-component programs may reduce individual and societal burden of psychotic disorders. In 2016, the Pennsylvania (PA) Office of Mental Health and Substance Abuse Services (OMHSAS) provided funding to develop a statewide Program Evaluation (PE) initiative. PA-FEP-PE assesses benefits of nine PA coordinated specialty care (CSC) programs both individually and in aggregate. We previously (SIRS 2019) presented preliminary data from initial pa

APA, Harvard, Vancouver, ISO, and other styles

32

Qambar M. Bokhari, Iram Zehra Bokharey*, Shahid H. Warris, Nauman Mazhar, Nadeem Akhtar, and Irum Fatima. "Urdu Translation and Adaptation of Glasgow Antipsychotic Side-Effect Scale (GASS)." PJPPRP 14, no. 1 (2023). http://dx.doi.org/10.62663/pjpprp.v14i1.22.

Full text

Abstract:

The main objective of the study was “Urdu translation and cultural adaptation” of Glasgow Anti-psychotic Side-effect Scale (GASS). The study comprised two phases and employed a combined methods design. Multiple Forward Translation Method was used to translate and adapt GASS, and a pre-clinical version was administered to 58 indoor patients. Later, psychometric properties and gender patterns of side effects were assessed. The pre-final version of the tool had good content validity with S-CVI of .94 and I-CVIs of .8 to .1. The Cronbach alpha for men indicated good internal consistency and reliab

APA, Harvard, Vancouver, ISO, and other styles

33

Maria, Nystazaki. "Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in Greece." Journal of Psychology & Clinical Psychiatry 1, no. 4 (2014). http://dx.doi.org/10.15406/jpcpy.2014.01.00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

S, Zikria. "Comparative Safety Profile of Single Versus Combination Antipsychotic Therapy by Using Glassgow Antipsychotic Side Effect Scale (Gass)." Neurology & Neurotherapy Open Access Journal 2, no. 2 (2017). http://dx.doi.org/10.23880/nnoaj-16000115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Kølbæk, Pernille, Ole Mors, Christoph U. Correll, and Søren D. Østergaard. "Treatment of schizophrenia evaluated via the pharmacopsychometric triangle—An integrative approach with emphasis on well-being and functioning." Schizophrenia 9, no. 1 (2023). http://dx.doi.org/10.1038/s41537-023-00420-6.

Full text

Abstract:

AbstractQuantification of treatment response is crucial to optimize outcomes for patients with schizophrenia. In this study, we evaluated the relationship between quantitative measures of clinician-rated symptom severity and self-rated side effects, well-being, and functioning among inpatients with schizophrenia using the six-item version of the Positive and Negative Syndrome Scale (PANSS-6), the Glasgow Antipsychotic Side-effect Scale (GASS), the WHO-Five Well-being Index (WHO-5), and the Sheehan Disability Scale (SDS). All measurements were conducted as close to admission and discharge as po

APA, Harvard, Vancouver, ISO, and other styles

36

Yahya, Ahmed Saeed. "Identifying Significant Antipsychotic-Related Side Effects in Patients on a Community Psychiatric Rehabilitation Unit-A Feasibility Study of The Glasgow Antipsychotic Side-Effect Scale (GASS)." Examines in Physical Medicine & Rehabilitation 2, no. 1 (2018). http://dx.doi.org/10.31031/epmr.2018.02.000529.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

"Validity and Reliability of the Turkish Version of the Glasgow Antipsychotic Side Effect Scale." Journal of Clinical Psychiatry, 2020. http://dx.doi.org/10.5505/kpd.2020.94547.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!